Prisys Biotechnology focuses on developing animal models for human diseases related to the nervous system, cardiovascular system and other areas. We aim to be an innovator and leader in NHP disease modeling field.
Prisys Biotechnology has an advanced CNS neurological disease modeling research platform, which can provide various types of non-human primate (NHP, crab-eating macaque) central nervous system disease models, such as chronic neuropathic pain, Parkinson's disease, hallucination, depression and stroke. These models have high reliability, reproducibility and similarity to human diseases, and can be used to validate and evaluate various neurological interventions and treatments.
Prisys Biotechnology also has advanced equipment and technology for comprehensive evaluation of these models, such as MRI, CT, DSA, electrophysiology recording, 3D behavior analysis, cognitive function test and so on.
Prisys Biotechnology also innovates new methods and schemes for expanding new fields of neurological disease modeling, such as DSA-guided MCAO model, hallucinogen-induced hallucination model, AI-based markerless 3D behavior analysis system and so on.
Prisys Biotechnology also provides multiple co-development options with customers, such as technology transfer, joint research and development, customized service and so on.
Prisys Biotechnology also pays attention to animal welfare and ensures that all experiments comply with the highest ethical standards.
Prisys Biotechnology's CNS neurological disease modeling research platform can be widely used for various purposes related to neurological diseases, such as studying their pathogenesis and pathophysiology, screening and evaluating new drugs and therapies, assessing and improving neural and cognitive functions, promoting and exploring neural protection and regeneration, developing and implementing personalized and precision medicine and so on.
Prisys Biotechnology has cooperated with many well-known domestic and foreign pharmaceutical companies to provide them with high-quality NHP central nervous system disease model services, helping them to select and evaluate new drugs and therapies for neurological diseases.
Prisys Biotechnology will showcase its leading CNS neurological disease modeling research platform at the 16th National Conference of the Chinese Neuroscience Society and the 2nd China-Japan-Korea International Conference, which will be held in Zhuhai, Guangdong from July 27 to 30, 2023.
This is one of the most important academic events in the field of neuroscience, which will gather many experts and scholars from home and abroad to discuss the mechanisms and treatments of neurological diseases and to promote the development of neuroscience.
Prisys Biotechnology welcomes you to have in-depth exchanges with us and jointly advance neuroscience. We look forward to meeting you at the 16th National Conference of the Chinese Neuroscience Society!
